Liposomal Eribulin (E7389-LF) Plus Nivolumab: A Potential Treatment Option For Patients With Advanced Gastric Cancer?

Authors

Ali Raza Shaikh, Thomas Jefferson UniversityFollow
Daniel Lin, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

10-21-2024

Comments

This article is the author's final published version in Journal of Gastrointestinal Oncology, Volume 15, Issue 5, October 2024, Pages 2343 - 2348.

The published version is available at https://doi.org/10.21037/jgo-24-415. Copyright © AME Publishing Company.

Recommended Citation

Shaikh, Ali Raza and Lin, Daniel, "Liposomal Eribulin (E7389-LF) Plus Nivolumab: A Potential Treatment Option For Patients With Advanced Gastric Cancer?" (2024). Jefferson Hospital Staff Papers and Presentations. Paper 43.
https://jdc.jefferson.edu/tjuhpapers/43

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English